When you join MSK Healthy Living, our experts will create a personal lifestyle plan for you. First, you will fill out a questionnaire that asks you questions about your goals and needs. The survey is ...

Su equipo de atención puede recomendar terapias sistémicas para tratar el cáncer pulmonar. Es posible que reciba terapia neoadyuvante, que es el tratamiento que se administra antes de la cirugía para ...

What type of lung cancer do I have, and what stage is it? Did I have all the scans I need to learn the stage? What genetic testing do you offer for lung cancer? What are the best treatment options for ...

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to ...

Full Title A Phase II Randomized Study Comparing Ibrutinib and Rituximab vs. Venetoclax and Rituximab in Previously Untreated Waldenström's Macroglobulinemia (WM) /Lymphoplasmacytic Lymphoma ...

I am currently a PhD student working in the labs of Dr. Daniel Heller and Dr. Raphael Lis. Here I am using organoid models to further our understanding of heterogeneity across brain vasculature, and ...

Discover the joys of crafting your very own DIY terrarium and transform your space into a green oasis! Whether this is your first time or you are a crafty botanical enthusiasts, this virtual workshop ...

New research from Memorial Sloan Kettering Cancer Center (MSK) finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is ...

This most recent clinical trial examined whether participating in virtually delivered, live classes including yoga, tai chi, meditation, fitness, and other integrative therapies could benefit patients ...

Memorial Sloan Kettering Cancer Center (MSK) announced today that Jeffrey A. Drebin, MD, PhD, has been named Chief Physician Executive. A renowned surgeon-scientist, Dr. Drebin previously served as ...

Study Results The primary endpoint was met in all three study populations at the first interim analysis as follows: (1) IIn the CPS ≥ 10 population, the EFS at 36 months was 60% in the pembrolizumab ...

Survival With Less Treatment Dr. Lee has led multiple studies showing that some head and neck cancers can be successfully treated with reduced radiation doses. This technique has already changed ...